control group:watch and wait

2 trials

Sponsors

Zhongshan Affiliated Hospital, Guangzhou University of Chinese Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University

Conditions

Colorectal cancerIndolent Lymphoma

Phase 4

Capecitabine metronomic chemotherapy for maintenance treatment of metastatic colorectal cancer after reaching NED (no evidence of disease): a prospective, single center, randomized, controlled clinical study

RecruitingChiCTR2100047149

Zhongshan Affiliated Hospital, Guangzhou University of Chinese MedicineColorectal cancer

Start: 2021-07-01Updated: 2022-01-24

Unknown Phase

A prospective, randomized, controlled, multicenter clinical study on the intervention of indolent lymphoma with the "Jieduxiaoluo Formula"

Active, not recruitingITMCTR2026000851

The First Affiliated Hospital of Zhejiang Chinese Medical UniversityIndolent Lymphoma

Start: 2026-06-01Updated: 2026-04-28

Related Papers

Capecitabine metronomic chemotherapy for metastatic colorectal cancer patients reaching NED: A protocol for a prospective, randomized, controlled trial

PLoS ONE2025-04-21